Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STATUS STUDY: Pilot Open-Label Trial of Intravenous Erenumab in Patients With Status Migrainosus

NCT04920331 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04920331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04920331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STATUS STUDY: Pilot Open-Label Trial of Intravenous Erenumab in Patients With Status Migrainosus
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Withdrawn
Start date
September 7, 2021
Completion date
February 4, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

status migrainosus